ctDNA Identifies Colon Cancer Patients Who Can Skip Chemo ctDNA Identifies Colon Cancer Patients Who Can Skip Chemo
A liquid biopsy to detect circulating tumor DNA after surgery for stage 2 colon cancer reduces the use of chemotherapy without sacrificing recurrence-free survival.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Health | Hematology